#China #Beijing #shareholder meeting #Cancer Care #Concord Medical

Concord Medical's 2025 Annual Shareholder Meeting Announcement

On December 2, 2025, Concord Medical Services Holdings Limited, a prominent healthcare provider specializing in cancer treatment and research, revealed plans for its 2025 Annual Shareholder Meeting (AGM). This significant event will take place on December 29, 2025, at 10:00 AM Beijing Time. The meeting will be hosted at the East Tower of the Hanwei Building located at No. 7 Guanghua Road, Chaoyang District, Beijing, China.

Details of the Meeting

The shareholder record date is set for December 19, 2025, meaning that only those shareholders who own shares by this date will be eligible to participate in the meeting. It’s important to note that no specific proposals will be on the agenda for approval during the AGM. Instead, the gathering will serve as a platform for shareholders to engage in discussions regarding the company's ongoing operations, strategy, and future plans with the management.

Financial Oversight and Reports

Concord Medical has committed to keeping its investors informed of the company's financial health through its annual report. The 2024 audited financial statements have been filed with the U.S. Securities and Exchange Commission and can be accessed in the Investor Relations section of Concord Medical's website. This effort underscores the company's dedication to transparency and informed shareholder participation.

About Concord Medical

Concord Medical Services is a leader in oncology services, offering a comprehensive range of medical care that includes cancer diagnosis, treatment, education, and preventive measures. The company emphasizes a multidisciplinary approach to cancer care, integrating various specialties to enhance patient outcomes. Furthermore, Concord Medical is distinguished by its commitment to advanced technology, featuring cutting-edge equipment like proton therapy systems that facilitate more effective treatment options.

The management expresses strong intentions to improve both the quality and accessibility of cancer care throughout China. Their strategy involves expanding their network, which includes self-owned cancer hospitals and partnerships with other medical facilities, focusing on delivering superior oncology services to patients.

Accessibility and Safety

In light of the ongoing health concerns and to uphold the wellbeing of all attendees, Concord Medical has made arrangements to ensure that the meeting complies with any requisite health guidelines that may be in effect at the time of the AGM. This reflects the company's focus on safety and the comfort of its shareholders.

Conclusion

As Concord Medical gears up for this pivotal meeting, it remains committed to fostering a culture of active shareholder engagement and open dialogue. The AGM presents an opportunity for stakeholders to grasp the company’s strategic direction and further their understanding of its initiatives and advancements in cancer care. For those interested in more detailed information, including the complete notice of the meeting, it is available on their Investor Relations website at Concord Medical IR.

This annual meeting not only serves as a key moment for shareholders to evaluate the company's performance but also highlights Concord Medical's relentless pursuit of innovation in the healthcare sector, aimed specifically at providing top-tier cancer treatment solutions in an ever-evolving medical landscape.